Kerry, J., Godfrey, L., Repapi, E., Tapia, M., Blackledge, N., Ma, H., . . . Milne, T. (2017). MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. Cell Press.
Dyfyniad Arddull ChicagoKerry, J., et al. MLL-AF4 Spreading Identifies Binding Sites That Are Distinct from Super-Enhancers and That Govern Sensitivity to DOT1L Inhibition in Leukemia. Cell Press, 2017.
Dyfyniad MLAKerry, J., et al. MLL-AF4 Spreading Identifies Binding Sites That Are Distinct from Super-Enhancers and That Govern Sensitivity to DOT1L Inhibition in Leukemia. Cell Press, 2017.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.